Last €49.28 EUR
Change Today -0.095 / -0.19%
Volume 692.3K
DSM On Other Exchanges
Symbol
Exchange
OTC US
EN Amsterdam
Frankfurt
OTC US
As of 11:35 AM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

koninklijke dsm nv (DSM) Snapshot

Open
€48.90
Previous Close
€49.37
Day High
€49.41
Day Low
€48.75
52 Week High
01/8/14 - €58.60
52 Week Low
10/16/14 - €43.61
Market Cap
8.9B
Average Volume 10 Days
680.6K
EPS TTM
€1.72
Shares Outstanding
181.4M
EX-Date
08/6/14
P/E TM
28.6x
Dividend
€1.70
Dividend Yield
3.45%
Current Stock Chart for KONINKLIJKE DSM NV (DSM)

Related News

No related news articles were found.

koninklijke dsm nv (DSM) Related Businessweek News

View More BusinessWeek News

koninklijke dsm nv (DSM) Details

Koninklijke DSM N.V. operates as a life sciences and materials sciences company worldwide. The company operates in five segments: Nutrition, Pharma, Performance Materials, Polymer Intermediates, and Innovation Center. It manufactures food enzymes, cultures, savory ingredients, and other specialties, as well as nutritional products, such as vitamins, carotenoids, eubiotics, feed enzymes, premixes, nutritional lipids, and cultures for the food and beverage, feed, personal care, dietary supplements, and pharmaceutical industries. The company also provides custom manufacturing and development services to the pharmaceutical, biopharmaceutical, and agrochemical industries; and beta-lactam active pharmaceutical ingredients, such as semi-synthetic penicillins and semi-synthetic cephalosporins, as well as nystatin. In addition, it offers engineering thermoplastic solutions; Dyneema, a strong fiber; and resins solutions for paints and coatings, composite materials, and optical fiber coatings. Further, the company produces caprolactam and acrylonitrile that are raw materials for synthetic fibers and plastics; and other products, including ammonium sulfate, sodium cyanide, cyclohexanone, and diaminobutane. Additionally, it develops materials-based solutions comprising coatings, drug delivery platforms, and a range of biomedical materials for medical device and biopharmaceutical industries; creates solutions for bioconversion of feedstocks for the production of bio-energy, such as cellulosic biofuels, as well as bio-based chemicals and materials; and provides smart coatings and surface technologies to the solar industry. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

21,477 Employees
Last Reported Date: 11/4/14
Founded in 1902

koninklijke dsm nv (DSM) Top Compensated Officers

Chairman of Managing Board, Chief Executive O...
Total Annual Compensation: €1.4M
Chief Financial Officer and Member of the Man...
Total Annual Compensation: €902.0K
Member of The Managing Board
Total Annual Compensation: €954.0K
Member of Managing Board
Total Annual Compensation: €887.0K
Member of The Managing Board
Total Annual Compensation: €268.0K
Compensation as of Fiscal Year 2013.

koninklijke dsm nv (DSM) Key Developments

Groupe Sebbin to Distribute DSM's Meso Biomatrix Acellular Peritoneum Matrix in Europe and Latin America

DSM announced a long-term partnership with Groupe Sebbin. Groupe Sebbin will market and distribute DSM's Meso BioMatrix Acellular Peritoneum Matrix in Europe and Latin America. The Meso BioMatrix Acellular Peritoneum Matrix is the newest addition to a family of extracellular matrix devices processed using DSM's proprietary OPTRIX manufacturing process. There are estimated to be more than 1.7 million new cases of breast cancer reported each year throughout the world. With the increased attention on therapeutic and preventative treatments, as well as recent advance in surgical intervention procedures for managing breast cancer, many women are being offered and opting for breast reconstruction as an aid to restoring a sense of well-being. Designed and developed by DSM, Meso BioMatrix Acellular Peritoneum Matrix is a surgical mesh that provides easy handling for surgeons with the strength necessary to reinforce soft tissue in breast reconstruction procedures.

DSM Announces Executive Changes, Effective January 1, 2015

DSM announced that it has appointed Ilona Haaijer CEO at its Food Specialities division, effective January 1, 2015. Haaijer will succeed Hans Christian Ambjerg who will head the innovation unit of the group's Nutritional Products division.

DSM Presents at Pacific Rim Summit 2014, Dec-08-2014 10:30 AM

DSM Presents at Pacific Rim Summit 2014, Dec-08-2014 10:30 AM. Venue: San Diego, California, United States. Speakers: Tim Hitchman.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSM:NA €49.28 EUR -0.095

DSM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Grupo Bimbo SAB de CV $37.05 MXN +0.39
Huntsman Corp $22.27 USD +0.93
LANXESS AG €37.37 EUR +0.58
Merck KGaA €77.08 EUR +0.209
Solvay SA €106.60 EUR -0.30
View Industry Companies
 

Industry Analysis

DSM

Industry Average

Valuation DSM Industry Range
Price/Earnings 63.6x
Price/Sales 0.9x
Price/Book 1.4x
Price/Cash Flow 43.9x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE DSM NV, please visit www.dsm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.